Antibiotic-containing collagen for the treatment of bone defects

Abstract

Recent studies have explored the use of biodegradable implants that incorporate antibiotics for the treatment of bone infections. In this study, a biodegradable composite containing bovine collagen and teicoplanin (Targobone®) was used for the treatment of mandibular nonunion defects. Patients with mandibular nonunion defects subsequent to osteosynthesis were treated with Targobone® (n = 9) or with autologous bone grafts (n = 12). Clinical and radiological evaluations were performed preoperatively, immediately post-operatively, and 4 and 24 weeks postoperatively. Bone regeneration was defined relative to the original defect area in the panoramic radiograph by using image analysis software. In the Targobone" group, the defect area decreased to 78% (SD ± 21.8%) of the preoperative area within 4 weeks and to 21% (SD ± 9.7%) of the preoperative area within 24 weeks. In the autologous bone graft group, the defect area decreased to 69% (SD ± 32.4%) of the preoperative area within 4 weeks and to 4.7% (SD ± 5.6%) of the preoperative area within 24 weeks. Thus, Targobone® is a promising option for the treatment of bone defects. © 2007 Wiley Periodicals, Inc.